| aa | Amino acid |
| alloHSCT | Allogeneic hematopoietic stem cell transplant |
| AML | Acute myeloid leukemia |
| CK-AML | Complex karyotype AML |
| CML | Chronic myeloid leukemia |
| CN | Cytogenetically normal |
| CR | Complete remission |
| Del | Deletion |
| DFS | Disease-free survival |
| EFS | Event-free survival |
| FLT3 | FMS-like tyrosine kinase 3 |
| FLT3L | FLT3 ligand |
| FLT3-mut | FLT3 mutation |
| HSC | Hematopoietic stem/progenitor cell |
| IL-3 | Interleukin-3 |
| Indels | Small insertions or deletions |
| ITD | Internal tandem duplication |
| LI-C | Leukemia-inducing cells |
| LSCs | Leukemic stem cells |
| MDS | Myelodysplastic syndrome |
| MLL-PTD | MLL-partial tandem duplication |
| MRD | Minimal residual disease |
| OS | Overall survival |
| PDGF | Platelet-derived growth factor |
| PR | Partial remission |
| RFS | Relapse-free survival |
| RTK | Receptor tyrosine kinase |
| TK | Tyrosine kinase |
| TKD | Tyrosine kinase domain |
| TKIs | Tyrosine kinase inhibitors |